To Our Aus. director, page-9

Coordination of a diverse shareholder group that are mostly anonymous would be difficult to impossible to bring together. My thought is for us to put together a bullet point list of responses that we would like from management and pick a date, say next Monday and all, using their real names email investor relations including the number of shares that you own. If the list is consistent from all shareholders it should have an impact. However, remember in the Q&A after the Special Shareholders Meeting John Ryan said he understood shareholders frustrations, he did not say he cared or would do anything about it. Below are a few starting points for others to make additions to:

1) Current production capacity of syringes, Wearable Injectors, Auto Injectors
2) Capital Plan
3) Update on previously announced agreements including AbbVie
4) Revenue or production Guidance short and long term

If you agree please begin adding questions.